Screening of the NIH Clinical Collection for inhibitors of HIV-1 integrase activity
Drug repurposing offers a validated approach to reduce drug attrition within the drug discovery and development pipeline through the application of known drugs and drug candidates to treat new indications. Full exploitation of this strategy necessitates the screening of a vast number of molecules ag...
Main Authors: | Shaakira Abrahams, Salerwe Mosebi, Muhammed Q. Fish, Maria A. Papathanasopoulos, Raymond Hewer |
---|---|
Format: | Article |
Language: | English |
Published: |
Academy of Science of South Africa
2018-03-01
|
Series: | South African Journal of Science |
Subjects: | |
Online Access: | https://www.sajs.co.za/article/view/4822 |
Similar Items
-
Fluorescence interference of polyphenols in assays screening for dipeptidyl peptidase IV inhibitory activity
by: Stoyan Dirimanov, et al.
Published: (2020-12-01) -
Pharmacokinetic drug interactions of integrase strand transfer inhibitors
by: Chi-Hua Lu, et al.
Published: (2021-01-01) -
Assessing Genotoxicity of Ten Different Engineered Nanomaterials by the Novel Semi-Automated FADU Assay and the Alkaline Comet Assay
by: Sarah May, et al.
Published: (2022-01-01) -
Different Pathways Conferring Integrase Strand-Transfer Inhibitors Resistance
by: Clémence Richetta, et al.
Published: (2022-11-01) -
HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment
by: Emma G. Foster, et al.
Published: (2022-12-01)